Literature DB >> 22476413

Evaluation of the binding of oxovanadium(IV) to human serum albumin.

Isabel Correia1, Tamás Jakusch, Enoch Cobbinna, Sameena Mehtab, Isabel Tomaz, Nóra V Nagy, Antal Rockenbauer, João Costa Pessoa, Tamás Kiss.   

Abstract

The understanding of the biotransformations of insulin mimetic vanadium complexes in human blood and its transport to target cells is an essential issue in the development of more effective drugs. We present the study of the interaction of oxovanadium(iv) with human serum albumin (HSA) by electron paramagnetic resonance (EPR), circular dichroism (CD) and visible absorption spectroscopy. Metal competition studies were done using Cu(II) and Zn(II) as metal probes. The results show that V(IV)O occupies two types of binding sites in albumin, which compete not only with each other, but also with hydrolysis of the metal ion. In one of the sites the resulting V(IV)O-HSA complex has a weak visible CD signal and its X-band EPR spectrum may be easily measured. This was assigned to amino acid side chains of the ATCUN site. The other binding site shows stronger signals in the CD in the visible range, but has a hardly measurable EPR signal; it is assigned to the multi metal binding site (MBS) of HSA. Studies with fatted and defatted albumin show the complexity of the system since conformational changes, induced by the binding of fatty acids, decrease the ability of V(IV)O to bind albumin. The possibility and importance of ternary complex formation between V(IV)O, HSA and several drug candidates - maltol (mal), picolinic acid (pic), 2-hydroxypyridine-N-oxide (hpno) and 1,2-dimethyl-3-hydroxy-4(1H)-pyridinone (dhp) was also evaluated. In the presence of maltol the CD and EPR spectra significantly change, indicating the formation of ternary VO-HSA-maltol complexes. Modeling studies with amino acids and peptides were used to propose binding modes. Based on quantitative RT EPR measurements and CD data, it was concluded that in the systems with mal, pic, hpno, and dhp (V(IV)OL(2))(n)(HSA) species form, where the maximum value for n is at least 6 (mal, pic). The degree of formation of the ternary species, corresponding to the reaction V(IV)OL(2) + HSA -->/<-- V(IV)OL(2)(HSA) is hpno > picmal > dhp. (V(IV)OL)(n)(HSA) type complexes are detected exclusively with pic. Based on the spectroscopic studies we propose that in the (V(IV)OL(2))(n)(HSA) species the protein bounds to vanadium through the histidine side chains.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22476413     DOI: 10.1039/c2dt12193j

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  8 in total

1.  New heteroleptic oxidovanadium(V) complexes: synthesis, characterization and biological evaluation as potential agents against Trypanosoma cruzi.

Authors:  Gonzalo Scalese; Ignacio Machado; Carolina Fontana; Gastón Risi; Gustavo Salinas; Leticia Pérez-Díaz; Dinorah Gambino
Journal:  J Biol Inorg Chem       Date:  2018-09-08       Impact factor: 3.358

2.  Copper(II) and oxidovanadium(IV) complexes of chromone Schiff bases as potential anticancer agents.

Authors:  Patrique Nunes; Yasemin Yildizhan; Zelal Adiguzel; Fernanda Marques; João Costa Pessoa; Ceyda Acilan; Isabel Correia
Journal:  J Biol Inorg Chem       Date:  2021-11-24       Impact factor: 3.358

3.  Comparison of the Effects on Bovine Serum Albumin Induced by Different Forms of Vanadium.

Authors:  Qionghua Zhang; Yanxuan Ma; Hongrui Liu; Jiali Gu; Xuekai Sun
Journal:  Biol Trace Elem Res       Date:  2022-08-01       Impact factor: 4.081

4.  Multiple and Variable Binding of Pharmacologically Active Bis(maltolato)oxidovanadium(IV) to Lysozyme.

Authors:  Giarita Ferraro; Maddalena Paolillo; Giuseppe Sciortino; Eugenio Garribba; Antonello Merlino
Journal:  Inorg Chem       Date:  2022-10-07       Impact factor: 5.436

Review 5.  Vanadium: History, chemistry, interactions with α-amino acids and potential therapeutic applications.

Authors:  Edgar Del Carpio; Lino Hernández; Carlos Ciangherotti; Valentina Villalobos Coa; Lissette Jiménez; Vito Lubes; Giuseppe Lubes
Journal:  Coord Chem Rev       Date:  2018-06-21       Impact factor: 22.315

6.  ESI-MS Study of the Interaction of Potential Oxidovanadium(IV) Drugs and Amavadin with Model Proteins.

Authors:  Valeria Ugone; Daniele Sanna; Giuseppe Sciortino; Debbie C Crans; Eugenio Garribba
Journal:  Inorg Chem       Date:  2020-06-25       Impact factor: 5.165

7.  Spectroscopic/Computational Characterization and the X-ray Structure of the Adduct of the VIVO-Picolinato Complex with RNase A.

Authors:  Giarita Ferraro; Nicola Demitri; Luigi Vitale; Giuseppe Sciortino; Daniele Sanna; Valeria Ugone; Eugenio Garribba; Antonello Merlino
Journal:  Inorg Chem       Date:  2021-11-30       Impact factor: 5.165

Review 8.  Vanadium in Biological Action: Chemical, Pharmacological Aspects, and Metabolic Implications in Diabetes Mellitus.

Authors:  Samuel Treviño; Alfonso Díaz; Eduardo Sánchez-Lara; Brenda L Sanchez-Gaytan; Jose Manuel Perez-Aguilar; Enrique González-Vergara
Journal:  Biol Trace Elem Res       Date:  2018-10-22       Impact factor: 3.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.